Boston Trust Walden Corp Has $53.49 Million Holdings in Plexus Corp. (NASDAQ:PLXS)

Boston Trust Walden Corp trimmed its position in Plexus Corp. (NASDAQ:PLXS - Free Report) by 2.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 391,238 shares of the technology company's stock after selling 10,001 shares during the quarter. Boston Trust Walden Corp owned 1.43% of Plexus worth $53,486,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in PLXS. UniSuper Management Pty Ltd acquired a new stake in shares of Plexus in the first quarter valued at approximately $515,000. Quantbot Technologies LP acquired a new position in Plexus in the 1st quarter valued at $533,000. Vanguard Group Inc. lifted its position in shares of Plexus by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 3,515,866 shares of the technology company's stock valued at $333,374,000 after acquiring an additional 74,988 shares during the period. Comerica Bank grew its holdings in shares of Plexus by 22.5% during the 1st quarter. Comerica Bank now owns 81,817 shares of the technology company's stock worth $7,758,000 after purchasing an additional 15,046 shares in the last quarter. Finally, Harbor Capital Advisors Inc. increased its position in shares of Plexus by 269.9% in the second quarter. Harbor Capital Advisors Inc. now owns 7,268 shares of the technology company's stock worth $750,000 after purchasing an additional 5,303 shares during the period. Institutional investors own 94.45% of the company's stock.

Plexus Price Performance

Shares of PLXS stock traded down $3.70 on Friday, reaching $141.19. The company had a trading volume of 318,082 shares, compared to its average volume of 128,867. The stock has a market capitalization of $3.84 billion, a PE ratio of 35.56 and a beta of 0.89. The company has a quick ratio of 0.64, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The business's 50-day moving average is $130.82 and its 200 day moving average is $116.26. Plexus Corp. has a one year low of $88.57 and a one year high of $153.60.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share for the quarter, beating analysts' consensus estimates of $1.55 by $0.30. The firm had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.64%. The company's quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the business posted $1.44 earnings per share. Equities research analysts forecast that Plexus Corp. will post 3.74 EPS for the current fiscal year.

Analysts Set New Price Targets

PLXS has been the topic of a number of analyst reports. Benchmark reiterated a "buy" rating and set a $150.00 price objective on shares of Plexus in a research note on Monday, October 21st. KeyCorp started coverage on shares of Plexus in a research report on Tuesday. They set a "sector weight" rating on the stock. Finally, Needham & Company LLC boosted their price objective on shares of Plexus from $144.00 to $162.00 and gave the company a "buy" rating in a research report on Friday. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Plexus has a consensus rating of "Hold" and an average price target of $129.75.

Insider Activity at Plexus

In other Plexus news, insider Steven J. Frisch sold 6,565 shares of the stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $128.11, for a total value of $841,042.15. Following the completion of the transaction, the insider now directly owns 36,118 shares in the company, valued at approximately $4,627,076.98. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Karen Marie Rapp sold 500 shares of the firm's stock in a transaction on Friday, August 30th. The stock was sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the transaction, the director now directly owns 9,586 shares of the company's stock, valued at $1,227,199.72. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Steven J. Frisch sold 6,565 shares of Plexus stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $128.11, for a total value of $841,042.15. Following the transaction, the insider now directly owns 36,118 shares in the company, valued at $4,627,076.98. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 20,113 shares of company stock valued at $2,541,394 in the last 90 days. 2.39% of the stock is owned by corporate insiders.

Plexus Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.